The role of intermittent androgen deprivation in prostate cancer.
Department of Urology, Hôpital Bichat, Paris, France. laurent.boccon-gibod@bch.ap-hop-paris.fr
Laurent
L
Boccon-Gibod
Peter
P
Hammerer
Stephan
S
Madersbacher
Nicolas
N
Mottet
Tommaso
T
Prayer-Galetti
Ulf
U
Tunn
D000726:Androgen Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D000728:Androgens / Q000378:metabolism; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011788:Quality of Life; D016896:Treatment Outcome
D000726:Androgen Antagonists; D000728:Androgens; D018931:Antineoplastic Agents, Hormonal